Lupin Pharmaceuticals, Inc, the US subsidiary of Indian generic firm Lupin Ltd, has received the final approval for imipramine pills to treat depression.
Matrix Laboratories, a subsidiary of Mylan Inc, has received final approval didanosine delayed-release capsules from the US FDA under the President's Emergency Plan for AIDS Relief (PEPFAR).
India's largest domestic firm Cipla Ltd is planning to launch low-priced misoprostol pills to control severe blood loss during pregnancy in India, reports said.
CEQ508, a once-daily oral therapy to treat colon polyps, is currently in clinical studies to evaluate its safety in humans, according to Cequent Pharmaceuticals.
Global pharma market is set reach $1.1 trillion by next five years growing at a pace of upto 8%, thanks to the emerging markets such as China and India, says IMS Market Prognosis.
Leprosy is still prevalent in certain parts of India, despite the country's achievements in eradicating the infectious disease.